Insulet Co. (NASDAQ: PODD) had its price target raised by analysts at TD Cowen from $264.00 to $324.00. They now have a "buy" rating on the stock.
GEHC vs. PODD: Which Stock Is the Better Value Option? [Yahoo! Finance]
Heavy Interest in Insulet's Insulin Delivery Device [Yahoo! Finance]
Insulet Corporation (NASDAQ:PODD) Delivered A Better ROE Than Its Industry [Yahoo! Finance]
Insulet Co. (NASDAQ: PODD) had its price target raised by analysts at JPMorgan Chase & Co. from $280.00 to $330.00. They now have an "overweight" rating on the stock.